InvestorsHub Logo
Followers 29
Posts 2160
Boards Moderated 0
Alias Born 06/15/2007

Re: kabunushi post# 241797

Saturday, 08/31/2019 8:03:12 PM

Saturday, August 31, 2019 8:03:12 PM

Post# of 701932
Seriously KABUN!! if the trial would have reached its stat sig endpoint , they would have terminated the trial long ago. You have to draw certain conclusions, yes some based on air!!! But based on an If this then that could have occurred.

I know nothing more or less than any other poster on this board. Mine is my own opinion loosely based in conjunction with similar opines from many who post here ... like flipper, doglogic, Longfellow, DR BALA etc

HAVING FOLLOWED this stock for years and owned for last two years, it’s my belief that what NWBO has learned about its drug over 10 + years in trial is what is causing a rewrite of the SAP

It is obvious to me and many that it didn’t meet the original endpoints or the trial would have been stopped

Thus it continued the trial to show the long tail of the survivors

And at 20-25% in the 3-5 year range this shows efficacy

But they didn’t have this kind of efficacy proof years ago

They do know
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News